Adma Biologics Inc2023财年实现净利润-28.24百万美元，同比增加57.15%

自选股智能写手03-04

12月31日，Adma Biologics Inc（ADMA.US）公布财报，公告显示公司2023财年净利润为-28.24百万美元，同比增加57.15%；其中营业收入为2.58亿美元，同比增加67.53%，每股基本收益为-0.13美元。从资产负债表来看，Adma Biologics Inc（ADMA.US）总负债1.94亿美元，其中短期债务1.05百万美元，资产负债比为1.70，流动比率为0.06...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2416901367?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-04 00:27","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2416901367","market":"us","top_or_hot":-1,"title":"Adma Biologics Inc2023财年实现净利润-28.24百万美元，同比增加57.15%","media":"自选股智能写手","content":"<div>\n<p>12月31日，Adma Biologics Inc（ADMA.US）公布财报，公告显示公司2023财年净利润为-28.24百万美元，同比增加57.15%；其中营业收入为2.58亿美元，同比增加67.53%，每股基本收益为-0.13美元。从资产负债表来看，Adma Biologics Inc（ADMA.US）总负债1.94亿美元，其中短期债务1.05百万美元，资产负债比为1.70，流动比率为0.06...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adma Biologics Inc2023财年实现净利润-28.24百万美元，同比增加57.15%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdma Biologics Inc2023财年实现净利润-28.24百万美元，同比增加57.15%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-04 00:27 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>12月31日，Adma Biologics Inc（ADMA.US）公布财报，公告显示公司2023财年净利润为-28.24百万美元，同比增加57.15%；其中营业收入为2.58亿美元，同比增加67.53%，每股基本收益为-0.13美元。从资产负债表来看，Adma Biologics Inc（ADMA.US）总负债1.94亿美元，其中短期债务1.05百万美元，资产负债比为1.70，流动比率为0.06...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADMA","symbol_name":"ADMA Biologics Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b","article_id":"2416901367","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2416901367","pubTimestamp":1709483246,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"12月31日，Adma Biologics Inc公布财报，公告显示公司2023财年净利润为-28.24百万美元，同比增加57.15%；其中营业收入为2.58亿美元，同比增加67.53%，每股基本收益为-0.13美元。从资产负债表来看，Adma Biologics Inc总负债1.94亿美元，其中短期债务1.05百万美元，资产负债比为1.70，流动比率为0.06。机构评级：截至2023年12月31日，当前有4家机构对Adma Biologics Inc目标价做出预测，其中目标均价为8.00美元，其中最低目标价为6.00美元，最高目标价为10.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"ADMA":"ADMA Biologics Inc"},"translate_title":"Adma Biology Inc achieved net profit of-US $28.24 million in fiscal year 2023, an increase of 57.15% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADMA":0.9},"content_text":"12月31日，Adma Biologics Inc（ADMA.US）公布财报，公告显示公司2023财年净利润为-28.24百万美元，同比增加57.15%；其中营业收入为2.58亿美元，同比增加67.53%，每股基本收益为-0.13美元。从资产负债表来看，Adma Biologics Inc（ADMA.US）总负债1.94亿美元，其中短期债务1.05百万美元，资产负债比为1.70，流动比率为0.06。机构评级：截至2023年12月31日，当前有4家机构对Adma Biologics Inc目标价做出预测，其中目标均价为8.00美元，其中最低目标价为6.00美元，最高目标价为10.00美元。公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、销售和开发特种血浆来源的生物制品，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。它的目标患者人群包括患有潜在的免疫缺陷疾病或由于医学原因可能受到免疫抑制的免疫功能低下的个体。 该公司将血浆衍生的中间馏分出售给某些客户，这些馏分是在FDA批准的IG和IVIG产品制造过程中生产的。 它还为某些客户提供实验室承包服务，并期望提供承包灌装、贴标和包装服务。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2416901367"}